Intramedullary spinal metastases are rare, occurring in ~1% of autopsied cancer patients, and are less common than leptomeningeal metastases.
Intramedullary lesions may result from:
- growth along the Virchow-Robin spaces
- haematogenous dissemination
- direct extension from leptomeninges
Demographics of affected patients reflect those of the underlying primary malignancy but over all the mean age of presentation is 55 years 7. They represent 8.5% of central nervous system metastases and account for 5% of all intramedullary lesions.
Intramedullary spinal cord metastasis most commonly occurs in the setting of advanced disease and only rarely is the first presentation of malignancy 7.
In contrast to the long duration of symptoms that are typical of primary intramedullary spinal neoplasms, up to 75% of patients with a spinal cord metastasis have symptoms for less than one month before diagnosis 2.
The most common presenting symptom is motor weakness. Other common presenting features are pain, bowel or bladder dysfunction, paraesthesia, or a rapid decline in neurological status in elderly patients 2.
The most commonly involved location is the cervical cord, followed by the thoracic cord and then the lumbar cord. Lesions are usually solitary and involve 2-3 vertebral body segments.
Hypervascular metastases may rarely be seen as enhancing intraspinal lesions.
Usually normal 6, although focal expansion or nodularity may be visible.
Lesions are usually well-defined 4 and typically produce cord expansion over several segments. In contrast to primary intramedullary neoplasms, associated cysts are rare. Typical MRI signal characteristics are:
- T1: hypointense
- prominent oedema commonly surrounds the tumour nodule
- T1 C+ (Gd): avid homogeneous enhancement
Treatment and prognosis
Management of intramedullary metastases generally consists of fractionated radiotherapy, which usually maintains but does not improve the pretreatment level of neurologic function. As with the treatment of brain metastases and epidural spinal cord compression, corticosteroids are used to diminish the effects of radiation-induced oedema 8.
Intramedullary metastases are associated with a poor prognosis. Up to two-thirds of patients die within six months of diagnosis 2.
General differential considerations include:
- other intramedullary spinal tumours, for example
- inflammatory lesions/transverse myelitis
- usually a longer length of cord involvement
- variable contrast enhancement
- rapidly progressive clinical course
- may not demonstrate enhancement
- less prominent cord expansion
- less prominent perilesional oedema
- lesions are usually multiple
- central cystic lesion
- no contrast enhancement
- 1. Grossman RI, Yousem DM. Neuroradiology, the requisites. Mosby Inc. (2003) ISBN:032300508X. Read it at Google Books - Find it at Amazon
- 2. Koeller KK, Rosenblum RS, Morrison AL. Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation. Radiographics. 20 (6): 1721-49. Radiographics (citation) - Pubmed citation
- 3. Abul-kasim K, Thurnher MM, Mckeever P et-al. Intradural spinal tumors: current classification and MRI features. Neuroradiology. 2008;50 (4): 301-14. doi:10.1007/s00234-007-0345-7 - Pubmed citation
- 4. Dam-hieu P, Seizeur R, Mineo JF et-al. Retrospective study of 19 patients with intramedullary spinal cord metastasis. Clin Neurol Neurosurg. 2009;111 (1): 10-7. doi:10.1016/j.clineuro.2008.06.019 - Pubmed citation
- 5. Pellegrini D, Quezel MA, Bruetman JE. Intramedullary spinal cord metastasis. Arch. Neurol. 2009;66 (11): 1422. doi:10.1001/archneurol.2009.245 - Pubmed citation
- 6. Kaya RA, Dalkiliç T, Ozer F et-al. Intramedullary spinal cord metastasis: a rare and devastating complication of cancer--two case reports. Neurol. Med. Chir. (Tokyo). 2003;43 (12): 612-5. Neurol. Med. Chir. (Tokyo) (link) - Pubmed citation
- 7. Connolly ES, Winfree CJ, Mccormick PC et-al. Intramedullary spinal cord metastasis: report of three cases and review of the literature. Surg Neurol. 1996;46 (4): 329-37. Surg Neurol (link) - Pubmed citation
- 8. Schiff D, O'neill BP. Intramedullary spinal cord metastases: clinical features and treatment outcome. Neurology. 1996;47 (4): 906-12. Neurology (citation) - Pubmed citation
- 9. Faugeras L, Cantineau G, Daisne JF, Gustin T, D’hondt L. Intramedullary spinal cord metastasis of cholangiocarcinoma: a case report. (2015) BMC Research Notes. 8 (1): 41. doi:10.1186/s13104-015-0998-y - Pubmed